Posts Tagged ‘patent expiration’

New patent expiration for Takeda Pharms drug ULORIC

Annual Drug Patent Expirations for ULORIC Uloric is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from four suppliers. There are five…
The post New patent expiration for Takeda Pharms drug ULORIC appeared first on Dru…


New patent expiration for Astellas drug ASTAGRAF XL

Annual Drug Patent Expirations for ASTAGRAF+XL Astagraf Xl is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Astellas drug ASTAGRAF XL appeared first…


New patent expiration for Eyepoint Pharms drug YUTIQ

Annual Drug Patent Expirations for YUTIQ Yutiq is a drug marketed by Eyepoint Pharms and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent expiration for Eyepoint Pharms drug YUTIQ appeared first on …


New patent expiration for Eyepoint Pharms drug YUTIQ

Annual Drug Patent Expirations for YUTIQ Yutiq is a drug marketed by Eyepoint Pharms and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent expiration for Eyepoint Pharms drug YUTIQ appeared first on …


New patent expiration for Bausch And drug RETISERT

Annual Drug Patent Expirations for RETISERT Retisert is a drug marketed by Bausch And Lomb and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Bausch And drug RETISERT appeared first on DrugP…


New patent expiration for Bausch And drug RETISERT

Annual Drug Patent Expirations for RETISERT Retisert is a drug marketed by Bausch And Lomb and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Bausch And drug RETISERT appeared first on DrugP…


New patent expiration for Alimera Sciences drug ILUVIEN

Annual Drug Patent Expirations for ILUVIEN Iluvien is a drug marketed by Alimera Sciences Inc and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for Alimera Sciences drug ILUVIEN appeared first…


New patent expiration for Alimera Sciences drug ILUVIEN

Annual Drug Patent Expirations for ILUVIEN Iluvien is a drug marketed by Alimera Sciences Inc and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for Alimera Sciences drug ILUVIEN appeared first…


Drug Patent Expirations for the Week of March 17, 2019

ILUVIEN (fluocinolone acetonide) Alimera sciences inc Patent: 6,548,078 Expiration: Mar 22, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirat…


New patent expiration for Ucb Inc drug NEUPRO

Annual Drug Patent Expirations for NEUPRO Neupro is a drug marketed by Ucb Inc and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Ucb Inc drug NEUPRO appeared first on DrugPatentWa…


Do NOT follow this link or you will be banned from the site!